The detection of anti-NLRP5 antibodies in a small subset of patients with non-APS1 ovarian insufficiency in a previous study further underlines the importance of evaluating the prevalence of anti-KHDC3L antibodies in women with POI (Brozzetti et al., 2015). This evidence concerns the gene NLRP5 and Autoimmune polyendocrinopathy type 1.